Status:

COMPLETED

Safety & Tolerability Study of CTP-499 in Patients With Moderate Chronic Kidney Disease

Lead Sponsor:

Concert Pharmaceuticals

Conditions:

Stage 3 Chronic Kidney Disease

Eligibility:

All Genders

18+ years

Phase:

PHASE1

Brief Summary

This study is being conducted to evaluate the safety and tolerability of treatment with CTP-499 in non-dialysis patients associated with moderate chronic kidney disease.

Detailed Description

This study will evaluate the safety and tolerability of treatment with CTP-499 starting with 600 milligrams (mg) once a day (QD) for 2 weeks followed by 600 mg twice a day (BID) for 2 weeks in non-dia...

Eligibility Criteria

Inclusion

  • Patient has a diagnosis of chronic kidney disease
  • If taking antihypertensive and antidiabetes medications, regimen must be stable for a minimum of 4 weeks
  • Patient has systolic blood pressure less than or equal to 160 mm Hg and diastolic blood pressure less than or equal to 95 mm Hg

Exclusion

  • Patient has concurrent condition such as uncontrolled inflammatory disease, acute infection or clinically unstable autoimmune, endocrine, neurological, psychiatric, retinal, cardiovascular, bronchopulmonary, hepatic, gastrointestinal or musculoskeletal disorder
  • Patient has acute, active and/or current unstable renal impairment disease
  • Patient has been hospitalized for acute renal failure in the past year
  • Patient has active malignancy or a history of neoplastic disease
  • Patient has QTc interval \> 450 milliseconds
  • Patient is currently on cytotoxic or other immunosuppressive therapy

Key Trial Info

Start Date :

August 1 2011

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

December 1 2011

Estimated Enrollment :

33 Patients enrolled

Trial Details

Trial ID

NCT01460199

Start Date

August 1 2011

End Date

December 1 2011

Last Update

May 24 2013

Active Locations (3)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (3 locations)

1

West Coast Clinical Trials

Costa Mesa, California, United States

2

Southern California Clinical Research

Garden Grove, California, United States

3

Orange County Research Center

Tustin, California, United States